DNA Topoisomerase I from Mycobacteria - A Potential Drug Target

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|8|22|1995-2007

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.8, Iss.22, 2002-10, pp. : 1995-2007

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

G-quadruplex DNA: a potential target for anti-cancer drug design

By Han H.   Hurley L.H.  

Trends in Pharmacological Sciences, Vol. 21, Iss. 4, 2000-04 ,pp. : 136-142

Elsevier

Access to resources Recommend Favorite

Targeting DNA Topoisomerase I with Non-Camptothecin Poisons

By  

Current Medicinal Chemistry, Vol. 19, Iss. 8, 2012-03 ,pp. : 1238-1257

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of DNA Topoisomerase I Inhibitors with Low-Cytotoxicity Based on Virtual Screening from Natural Products

By Xin Lan-Ting   Liu Lu   Shao Chang-Lun   Yu Ri-Lei   Chen Fang-Ling   Yue Shi-Jun   Wang Mei   Guo Zhong-Long   Fan Ya-Chu   Guan Hua-Shi   Wang Chang-Yun  

Marine Drugs, Vol. 15, Iss. 7, 2017-07 ,pp. : 217-217

MDPI

Access to resources Recommend Favorite

Phosphodiesterase-4 as a potential drug target

By Zhang Kam YJ   Ibrahim Prabha N   Gillette Sam   Bollag Gideon  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 6, 2005-12 ,pp. : 1283-1305

Informa Healthcare

Access to resources Recommend Favorite

Secalonic acid D as a novel DNA topoisomerase I inhibitor from marine lichen-derived fungus Gliocladium sp. T31

By Hong Ren  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 49, Iss. 8, 2011-08 ,pp. : 796-799

Informa Healthcare

Access to resources Recommend Favorite